Nabi Drops StaphVAX Following Failure Of Confirmatory Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm also halts development of S. aureus immune globulin Altastaph because it uses the same technology as the StaphVax S. aureus vaccine.